Quick Takeaways
- Vicki L. Sato has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $13,116,421.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Vicki L. Sato and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VIR | Vir Biotechnology, Inc. | Director | $10,858,643 | -$2,059,473 | -16% | 01 May 2026 |
| DNLI | Denali Therapeutics Inc. | Director | $2,257,778 | 02 Jan 2025 | ||
| AKUS | Akouos, Inc. | Director | 01 Dec 2022 | |||
| ALLO | Allogene Therapeutics, Inc. | Director | 18 Jun 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|